A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient

Takeshi Terashima, Eri Iwami, Shotaro Chubachi, Shinnosuke Ikemura, Takahiro Nakajima, Tatsu Matsuzaki, Hiroshi Aoyagi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In recent years, many patients have had to undergo hemodialysis due to chronic renal failure. In addition, the number of hemodialysis patients in whom lung cancer is discovered is increasing. However, a standard chemoradiotherapy regimen for limited-disease small-cell lung cancer patients undergoing maintenance hemodialysis has not yet been established. We administered concurrent chemoradiotherapy using carboplatin 300 mg/m2 (day 1) plus etoposide 50 mg/m2 (day 1, 3). A partial response was achieved after 4 courses of chemotherapy and 68 Gy of radiotherapy. The major toxicities were hematological toxicities; they included grade 4 thrombocytopenia, grade 3 anemia, and neutropenia.

Original languageEnglish
Pages (from-to)99-101
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume43
Issue number1
Publication statusPublished - 2016 Jan 1
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient'. Together they form a unique fingerprint.

  • Cite this